• News
  • SAN DIEGO
  • Medical

Adamis files new drug application with FDA

San Diego-based Adamis Pharmaceuticals Corp. (Nasdaq: ADMP) announced the submission of a new drug application (NDA) to the U.S. Food and Drug Administration for its epinephrine pre-filled single dose syringe (PFS) product.

The epinephrine injection USP 1:1000 is designed for the emergency treatment of allergic reactions (Type 1) including anaphylaxis.

Adamis' PFS provides a single dose of epinephrine (adrenaline), which is considered the drug of choice for immediate administration in acute anaphylactic reactions to insect stings or bites, allergic reaction to foods, drugs and other allergens, as well as idiopathic or exercise-induced anaphylaxis. Adamis' PFS is designed to be the low-cost, easy-to-use therapeutic alternative to existing epinephrine auto-injectors.

"We feel this NDA submission represents a major milestone for Adamis,” said Dennis Carlo, president and CEO of Adamis. “The epinephrine market is large and growing and we estimate auto-injector sales in the U.S. this year to approach $1 billion. I believe our PFS could be an affordable substitute for the costly auto-injectors. These types of markets have proven to be cost sensitive and we expect epinephrine to be no different. Our PFS could allow Adamis to generate significant revenues and in time lead to profitability."

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

User Response
0 UserComments

Leave Your Comment

Comments are moderated by SDDT, in accordance with the SDDT Comment Policy, and may not appear on this commentary until they have been reviewed and deemed appropriate for posting. Also, due to the volume of comments we receive, not all comments will be posted.

SDDT Comment Policy: SDDT encourages you to add a comment to this discussion. You may not post any unlawful, threatening, defamatory, obscene, pornographic or other material that would violate the law. All comments should be relevant to the topic and remain respectful of other authors and commenters. You are solely responsible for your own comments, the consequences of posting those comments, and the consequences of any reliance by you on the comments of others. By submitting your comment, you hereby give SDDT the right, but not the obligation, to post, air, edit, exhibit, telecast, cablecast, webcast, re-use, publish, reproduce, use, license, print, distribute or otherwise use your comment(s) and accompanying personal identifying and other information you provide via all forms of media now known or hereafter devised, worldwide, in perpetuity. SDDT Privacy Statement.

Adamis Pharmaceuticals Corp.

Company Website

11455 El Camino Real
San Diego, CA 92130

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ADMP
3.96
  0.09  
+ 2.33%
11,339,000
7.26
3.05

Adamis Pharmaceuticals Corp. Executive(s):

Dennis Carlo

  • Chief Executive Officer, President

Robert Hopkins

  • Chief Financial Officer

Similar Companies

NAICS - 325620 - Toilet Preparation Manufacturing
NAICS - 339112 - Surgical and Medical Instrument Manufacturing
Subscribe Today!